Table 6 |
|||
|
Incremental cost-effectiveness ratios |
|||
|
Incremental Cost Effectiveness Ratios |
Clinical |
Microscopy |
RDT |
|
|
|||
|
Cost/patient diagnosed |
2.7 |
8.2 |
4.7 |
|
|
|||
|
Effectiveness per case diagnosed |
0.25 |
0.79 |
0.91 |
|
|
|||
|
Moving from clinical to either microscopy or RDTs |
|||
|
|
|||
|
Incremental costs |
- |
5.5 |
2.0 |
|
|
|||
|
Incremental effects |
- |
0.54 |
0.66 |
|
|
|||
|
ICER |
10.2 |
3.0 |
|
|
|
|||
|
Cost/patient diagnosed and treated* |
4.2 |
9.4 |
5.9 |
|
|
|||
|
Effectiveness per case diagnosed |
0.25 |
0.79 |
0.91 |
|
|
|||
|
Moving from clinical to either microscopy or RDTs |
|||
|
|
|||
|
Incremental costs |
- |
5.2 |
1.7 |
|
|
|||
|
Incremental effects |
- |
0.54 |
0.66 |
|
|
|||
|
ICER (USD) |
9.6 |
2.6 |
|
|
|
|||
|
Chanda et al. Cost Effectiveness and Resource Allocation 2009 7:5 doi:10.1186/1478-7547-7-5 |
|||
